Compay is developing a proprietary form of sonodynamic therapy as a first-in-class, noninvasive drug-device combination to treat recurrent glioblastoma.
An interview with Nnamdi Njoku, president of Neuromodulation at Medtronic, to gain insights into current products and future advancements within the unit.
Axoft’s minimally invasive implants create a seamless interface with the nervous system, allowing ultra-high bandwidth and stable, single-neuron measurements.
Brain Navi's SMART tech merges machine vision, robotics, and AI technology to achieve streamlined surgical procedures with real-time imaging and MI outcomes.